Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Transgenic assays and the identification of carcinogens.
Tennant R, Haseman J, Stoll RE. Tennant R, et al. Among authors: stoll re. Environ Mol Mutagen. 2001;37(1):86-92. doi: 10.1002/1098-2280(2001)37:1<86::aid-em1010>;2-g. Environ Mol Mutagen. 2001. PMID: 11170246 No abstract available.
Transponder-induced sarcoma in the heterozygous p53+/- mouse.
Blanchard KT, Barthel C, French JE, Holden HE, Moretz R, Pack FD, Tennant RW, Stoll RE. Blanchard KT, et al. Among authors: stoll re. Toxicol Pathol. 1999 Sep-Oct;27(5):519-27. doi: 10.1177/019262339902700505. Toxicol Pathol. 1999. PMID: 10528631
Oxymetholone: III. Evaluation in the p53+/- transgenic mouse model.
Stoll RE, Holden HE, Barthel CH, Blanchard KT. Stoll RE, et al. Toxicol Pathol. 1999 Sep-Oct;27(5):513-8. doi: 10.1177/019262339902700503. Toxicol Pathol. 1999. PMID: 10528630
Cancer hazard identification: toward simplification and interpretability.
Stoll RE. Stoll RE. Toxicol Pathol. 1998 Jul-Aug;26(4):582-3. doi: 10.1177/019262339802600416. Toxicol Pathol. 1998. PMID: 9715519 No abstract available.
Hemizygous Tg.AC transgenic mouse as a potential alternative to the two-year mouse carcinogenicity bioassay: evaluation of husbandry and housing factors.
Holden HE, Stoll RE, Spalding JW, Tennant RW. Holden HE, et al. J Appl Toxicol. 1998 Jan-Feb;18(1):19-24. doi: 10.1002/(sici)1099-1263(199801/02)18:1<19::aid-jat464>;2-q. J Appl Toxicol. 1998. PMID: 9526830
Dermal carcinogenicity in transgenic mice: relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-O-tetradecanoylphorbol 13-acetate (TPA) and benzene.
Blanchard KT, Ball DJ, Holden HE, Furst SM, Stoltz JH, Stoll RE. Blanchard KT, et al. Toxicol Pathol. 1998 Jul-Aug;26(4):541-7. doi: 10.1177/019262339802600410. Toxicol Pathol. 1998. PMID: 9715513
Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA.
Thompson KL, Rosenzweig BA, Honchel R, Cannon RE, Blanchard KT, Stoll RE, Sistare FD. Thompson KL, et al. Among authors: stoll re. Mol Carcinog. 2001 Dec;32(4):176-86. doi: 10.1002/mc.10009. Mol Carcinog. 2001. PMID: 11746829
Tg.AC genetically altered mouse: assay working group overview of available data.
Eastin WC, Mennear JH, Tennant RW, Stoll RE, Branstetter DG, Bucher JR, McCullough B, Binder RL, Spalding JW, Mahler JF. Eastin WC, et al. Among authors: stoll re. Toxicol Pathol. 2001;29 Suppl:60-80. doi: 10.1080/019262301753178483. Toxicol Pathol. 2001. PMID: 11695563
Dermal carcinogenicity in transgenic mice: effect of vehicle on responsiveness of hemizygous Tg.AC mice to phorbol 12-myristate 13-acetate (TPA).
Stoll RE, Furst SM, Stoltz JH, Lilly PD, Mennear JH. Stoll RE, et al. Toxicol Pathol. 2001 Sep-Oct;29(5):535-40. doi: 10.1080/019262301317226339. Toxicol Pathol. 2001. PMID: 11695570
31 results
Jump to page